Sezary disease is a leukemic form of cutaneous T-cell lymphoma characterized by erythroderma, lymphadenopathy, and circulating malignant T-cells. The involvement of intrathoracic lymph nodes indicates a more advanced stage of the disease, which can complicate treatment and prognosis. Accurate coding with ICD-10 Code C84.12 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this serious condition.
ICD-10 Code C84.12 specifically denotes Sezary disease with involvement of intrathoracic lymph nodes. This condition is a subtype of cutaneous T-cell lymphoma, where malignant T-cells proliferate and can lead to systemic symptoms. This code should be used in clinical documentation and billing when a patient presents with the characteristic symptoms and confirmed diagnosis of Sezary disease affecting the intrathoracic lymph nodes.
Sezary disease is a severe form of cutaneous T-cell lymphoma that can progress to involve the lymphatic system, including intrathoracic lymph nodes. The condition arises from malignant transformation of T-lymphocytes, leading to systemic manifestations. Prompt medical attention is crucial due to the potential for rapid progression and complications.
ICD-10 Code C84.12 is utilized in SOAP notes to document the diagnosis of Sezary disease with intrathoracic lymph node involvement. This code aids in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C84.12 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Sezary disease affecting intrathoracic lymph nodes. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Sezary disease requires urgent medical intervention, often necessitating hospitalization for comprehensive management. Treatment typically involves systemic therapies tailored to the patient's condition.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.12 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique, for Sezary disease treatment. |
| 99214 | Established patient office visit, moderate complexity. |
| 85025 | Complete blood count with differential. |
| 88305 | Pathology examination of tissue biopsy. |
Common Questions About Using ICD-10 Code C84.12 for Sezary disease, intrathoracic lymph nodes
What are the common symptoms of Sezary disease?
Common symptoms include widespread skin redness (erythroderma), severe itching, swollen lymph nodes, and fatigue. Patients may also experience weight loss and systemic symptoms due to the disease's progression.
How is Sezary disease diagnosed?
Diagnosis is typically made through clinical evaluation, skin biopsy, and laboratory tests that reveal atypical T-cells in the blood. Imaging studies may also be used to assess lymph node involvement.
What treatments are available for Sezary disease?
Treatment options include systemic therapies such as chemotherapy, targeted therapies, and supportive care to manage symptoms. Hospitalization may be required for severe cases.
How does ICD-10 Code C84.12 impact billing?
ICD-10 Code C84.12 is essential for accurate billing as it specifies the diagnosis of Sezary disease with intrathoracic lymph node involvement, ensuring proper reimbursement and compliance with coding standards.
Clinical Notes
SOAP notes
DAP notes
AI medical notes